John T. Treace Sells $89.3M of Treace Medical Concepts Inc (TMCI) — SEC Form 4, Apr 29, 2021

Open-Market Net Sale · SEC Form 4

−$89,314,685

Equity position changed by -31.4%

Reporting Owner

John T. Treace

CEO 10% Owner

TXN 2021-04-27 · FILED 2021-04-29

Equity Position 10.8M sh 15,787,188 → 10,832,893

Equity Change -31.4% shares held after vs before

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Treace Medical Concepts Inc

TMCI CIK 0001630627

Reporting Owner

Name	Relationship
John T. Treace CIK 0001856380	Director CEO 10% Owner

John T. Treace at Treace Medical Concepts Inc Full insider history

Bought (12 mo) $1,351,631

Sold (12 mo) —

More from this insider at Treace Medical Concepts Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1	2021-04-27	C - Conversion	299,510 A		—	11,171,385	Direct
Common StockF2 F2	2021-04-27	S - Sale	5,253,805 D	$17.00	-$89,314,685	5,917,580	Direct

Derivative Securities Transactions

Title	Strike	Date	Type	Shares	Price	Expiration	Underlying	Ownership
Series A Preferred StockF1 F4 F1 F4 F1 F4		2021-04-27	J - Other	6,932 A	$0.00		6,932 Common Stock	Direct
Series A Preferred StockF1 F1 F1		2021-04-27	C - Conversion	299,510 D	$0.00		299,510 Common Stock	Direct

Non-Derivative Holdings

Footnotes (4)

F1: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. Show more
F2: These shares were sold by the Reporting Person as a selling stockholder in conjuction with the Issuer's Form S-1 filing, Registration Number 333-254863. The offering closed on April 27, 2021. The reported sale price reflects the price at which the Reporting Person sold shares to the underwriters. Show more
F3: The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee. Show more
F4: The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 4 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Treace Medical Concepts Inc

GET /v1/forms/4/0000899243-21-017486 API docs